Cargando…
Autophagy Is a Potential Target for Enhancing the Anti-Angiogenic Effect of Mebendazole in Endothelial Cells
Mebendazole (MBZ), a microtubule depolymerizing drug commonly used for the treatment of helminthic infections, has recently been noted as a repositioning candidate for angiogenesis inhibition and cancer therapy. However, the definite anti-angiogenic mechanism of MBZ remains unclear. In this study, w...
Autores principales: | Sung, So Jung, Kim, Hyun-Kyung, Hong, Yong-Kil, Joe, Young Ae |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Applied Pharmacology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6319545/ https://www.ncbi.nlm.nih.gov/pubmed/30642153 http://dx.doi.org/10.4062/biomolther.2018.222 |
Ejemplares similares
-
Modulation of Autophagy is a Potential Strategy for Enhancing the Anti-Tumor Effect of Mebendazole in Glioblastoma Cells
por: Jo, Seong Bin, et al.
Publicado: (2022) -
Albendazole and Mebendazole as Anti-Parasitic and Anti-Cancer Agents: an Update
por: Chai, Jong-Yil, et al.
Publicado: (2021) -
Enhancing Anti-Cancer Therapy with Selective Autophagy Inhibitors by Targeting Protective Autophagy
por: Lee, Min Ju, et al.
Publicado: (2023) -
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma
por: Li, Qian, et al.
Publicado: (2022) -
The Warburg Effect in Endothelial Cells and its Potential as an Anti-angiogenic Target in Cancer
por: Fitzgerald, Gillian, et al.
Publicado: (2018)